Piramal Pharma Limited (NSE: PPLPHARMA)

India flag India · Delayed Price · Currency is INR
239.70
-2.60 (-1.07%)
Jan 23, 2025, 3:30 PM IST
67.10%
Market Cap 317.78B
Revenue (ttm) 87.04B
Net Income (ttm) 453.30M
Shares Out 1.33B
EPS (ttm) 0.34
PE Ratio 701.04
Forward PE 79.11
Dividend 0.11 (0.05%)
Ex-Dividend Date n/a
Volume 4,850,441
Average Volume 5,600,540
Open 242.30
Previous Close 242.30
Day's Range 238.60 - 251.95
52-Week Range 114.35 - 307.90
Beta 0.11
RSI 47.92
Earnings Date Jan 22, 2025

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which off... [Read more]

Sector Healthcare
Founded 2020
Employees 6,719
Stock Exchange National Stock Exchange of India
Ticker Symbol PPLPHARMA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.